Katharine Ku is the executive director of the Stanford University Office of Technology Licensing, which is responsible for the licensing of various state-of-the-art university technologies and industry-sponsored research agreements, material transfer agreements and collaborations. In addition to leading Stanford’s pre-award Sponsored Projects Office, Ku has held various positions at Stanford and served as the vice president of business development at Protein Design Labs, Inc., in Mountain View, California. She is a member of the NIH Advisory Committee to the Deputy Director of Intramural Research and of the Biomedical Engineering Society’s Industry Advisory Board. Ku holds a B.S. in chemical engineering from Cornell University and an M.S. in chemical engineering from Washington University, and she is a registered patent agent.
-
Research
-
- Funding & Notices
- News & Media
- About Translation
-
- About NCATS
-
NCATS Programs & Initiatives
- 3-D Tissue Bioprinting Program
- A Specialized Platform for Innovative Research Exploration (ASPIRE)
- Assay Development and Screening Technology (ADST)
- Biomedical Data Translator
- Bridging Interventional Development Gaps (BrIDGs)
- Chemistry Technology
- Discovering New Therapeutic Uses for Existing Molecules
- Genetic and Rare Diseases Information Center (GARD)
- Matrix Combination Screening
- NCATS Chemical Genomics Center (NCGC)
- A Specialized Platform for Innovative Research Exploration (ASPIRE)
- NIH Common Fund Programs
- Rare Diseases Registry Program (RaDaR)
- Tissue Chip for Drug Screening
- Toxicology in the 21st Century (Tox21)
- Trans-NIH RNAi Facility (TNRF)
- Therapeutics for Rare and Neglected Diseases (TRND)
- About NCATS
- Home
- About NCATS
- Advisory Groups
- NCATS Advisory Council
- Council Roster
- Katharine Ku, M.S. (2020)
Katharine Ku, M.S. (2020)
- Funding & Notices
-